See All Slides - tctmd.com

Slides

Presentation TCT 2012

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

Presenter: Martin Leon

October 22, 2012

Presentation TCT 2012

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Presenter: Roxana Mehran

October 22, 2012

Presentation TCT 2012

Case 3(2)

Presenter: Horst Sievert

October 22, 2012

Presentation TCT 2012

Bifurcation Anatomy, Angulation, and Lesion Complexity: Implications for Procedural Outcomes and Long-term Patency

Presenter: Debabrata Dash

October 22, 2012

Presentation TCT 2012

Case Presentation (with Discussion): Recurrent DES Restenosis

Presenter: Simon Walsh

October 22, 2012

Presentation TCT 2012

REDUCE Trial Update

Presenter: John Rhodes

October 22, 2012

Presentation TCT 2012

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Presenter: Neil Weissman

October 22, 2012

Presentation TCT 2012

ASD Closure: The European Perspectives

Presenter: Horst Sievert

October 22, 2012

Presentation TCT 2012

Endpoint Selection: Focus on STEMI

Presenter: Stephen Ellis

October 22, 2012

Presentation TCT 2012

When Triple Therapy Is Needed: Warfarin, Dabigatran, Rivaroxaban, and Cilostazol Considerations

Presenter: Harvey White

October 22, 2012

Advertisement

Slides

A Visionary Look at the Cath Lab in 2020: Multispecialty, Multiple Imaging Modalities, Multiple Clinical Targets, Fully Integrated, and IT Enabled: A Cardiovascular Diagnostic...

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Case 3(2)

Bifurcation Anatomy, Angulation, and Lesion Complexity: Implications for Procedural Outcomes and Long-term Patency

Case Presentation (with Discussion): Recurrent DES Restenosis

REDUCE Trial Update

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

ASD Closure: The European Perspectives

Endpoint Selection: Focus on STEMI

When Triple Therapy Is Needed: Warfarin, Dabigatran, Rivaroxaban, and Cilostazol Considerations

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content